Effects of L-Carnitine supplementation on levels of inflammatory markers
The mean levels of inflammation markers before and after supplementation on 7 days are shown in Table 3. A significant decline was observed in serum IL-6 levels in the LC group (p<0.001), while IL-6 levels significantly increased in the placebo group (P=0.001), and the mean change between groups was statistically significant (P<0.001) in which LC group showed both clinical and statistical significant decline compared to placebo group. Likewise, in comparison to the baseline, at post intervention, CRP significantly decreased in the LC group though it did not change in the placebo group, and the difference between groups was statistically significant (P=0.009).